Oncolytic virotherapy, a new approach in graft-versus-host disease

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MIRFAKHRAIE R.; Kuhestani Dehaghi B.h.; MEHDIZADEH M.; KAZEMI M.H.; Roshandel E.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Yafteh Year:2022 | Volume:23 | Issue:5 Page(s): 1-13

Download Full-Text

Persian Verion

View:

592

Download:

Cites:

Information Journal Paper

Title

Oncolytic virotherapy, a new approach in graft-versus-host disease

Author(s)

Keywords

Graft-versus-host disease

Hematopoietic stem cell transplantation

Oncolytic viruses

Abstract

Background: Despite recent advances in Hematopoietic stem cell transplantation (HSCT), Graft-versus-host disease (GVHD) is still one of the most challenging post-transplant complications with a considerable mortality rate. Various strategies, including chemotherapy, depletion of T lymphocytes, monoclonal antibodies, corticosteroids, and other immunosuppressive drugs are used to reduce GVHD incidence, which usually increases the risk of cancer relapse and various infections in patients. The recently conducted studies have introduced oncolytic virotherapy as a promising solution to prevent GVHD and enhance the graft-versus-tumor effects. Oncolytic viruses are non-pathogenic viruses capable of selective lysis of cancer cells. These viruses can differentiate between allogeneic T lymphocytes and hematopoietic stem cells, and suppress allogeneic T cells. This review study aimed to discuss the mechanisms of oncolytic virotherapy in reducing the incidence of GVHD.

Cites

No record.

References

Cite

APA: Copy

MIRFAKHRAIE, R., Kuhestani Dehaghi, B.h., MEHDIZADEH, M., KAZEMI, M.H., & Roshandel, E.. (2022). Oncolytic virotherapy, a new approach in graft-versus-host disease. YAFTEH, 23(5 (90) ), 1-13. SID. https://sid.ir/paper/1018761/en

Vancouver: Copy

MIRFAKHRAIE R., Kuhestani Dehaghi B.h., MEHDIZADEH M., KAZEMI M.H., Roshandel E.. Oncolytic virotherapy, a new approach in graft-versus-host disease. YAFTEH[Internet]. 2022;23(5 (90) ):1-13. Available from: https://sid.ir/paper/1018761/en

IEEE: Copy

R. MIRFAKHRAIE, B.h. Kuhestani Dehaghi, M. MEHDIZADEH, M.H. KAZEMI, and E. Roshandel, “Oncolytic virotherapy, a new approach in graft-versus-host disease,” YAFTEH, vol. 23, no. 5 (90) , pp. 1–13, 2022, [Online]. Available: https://sid.ir/paper/1018761/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops